$76.00
Manufacturer: Ukraine
Monotherapy (first choice drug) for treatment: partial seizures with or without secondary generalization in adults and adolescents over 16 years of age who were first diagnosed with epilepsy. As an additional therapy for treatment: partial seizures with or without secondary generalization in adults and children with a body weight of 7 kg, patients with epilepsy (in this dosage form); myoclonic seizures in adults and adolescents over 12 years of age with juvenile myoclonic epilepsy; primary generalization of convulsive (tonic-clonic) seizures in adults and adolescents older than 12 years, patients with idiopathic generalized epilepsy.
Description
Levicitam tablets Composition
Active substance: levetiracetam;
1 tablet contains levetiracetam 250 mg or 500 mg;
Excipients: microcrystalline cellulose, copolyvidone, crospovidone, corn starch, magnesium stearate, coating for coating Opadry II White (polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide (E 171)).
Levicitam tablets Contraindications
Hypersensitivity to levetiracetam or other pyrrolidone derivatives, as well as to any excipients of the drug.
Levicitam tablets Mode of application
The tablets should be taken by mouth with a sufficient amount of liquid, with or without food. When taken orally, levetiracetam may have a bitter taste. Divide the daily dose into 2 equal doses.
Levicitam tablets Application features
Pregnant
Adequate clinical supervision should be provided for pregnant women receiving levetiracetam.
Children
The drug in the form of tablets is not recommended for use in children under 6 years of age.
Drivers
Carefully.
Overdose
In case of an overdose, drowsiness, agitation, aggression, respiratory depression, depression of consciousness, coma were observed.
In case of an acute overdose, it is necessary to flush the stomach or induce vomiting. There is no specific antidote for levetiracetam. If necessary, carry out symptomatic treatment, including with the use of hemodialysis (60% of levetiracetam and 74% of the main metabolite are excreted).
Side effects
The most commonly reported adverse reactions were nasopharyngitis, drowsiness, headache, fatigue, and dizziness.
Interaction
In some cases, a decrease in the effectiveness of levetiracetam has been reported with the simultaneous use of an osmotic laxative macrogol with oral levetiracetam. Therefore, macrogol should not be taken orally within one hour before and within one hour after taking levetiracetam.
The degree of absorption of levetiracetam does not depend on food, but the absorption rate is somewhat reduced if taken with food. There is no data on the interaction of levetiracetam with alcohol.
Storage conditions
Keep out of the reach of children, in its original packaging at a temperature not exceeding 25 ° C.
Shelf life is 3 years.
Recent Reviews